Cochrane Database of Systematic Reviews 2010
DOI: 10.1002/14651858.cd008277
|View full text |Cite
|
Sign up to set email alerts
|

Blood pressure targets for hypertension in patients with diabetes mellitus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…As discussed in the ACC/AHA guideline, this is mainly because there is limited quality evidence on this topic and no randomized trials directly demonstrated better clinical outcomes with intensive BP control <130/80 mm Hg in diabetic patients. 2,9 Therefore, more quality studies are needed to solve this uncertainty and guide clinical practice. Furthermore, cost-benefit analysis of treating diabetic patients with stage 1 hypertension would give us additional information from public health perspective.…”
Section: Discussionmentioning
confidence: 99%
“…As discussed in the ACC/AHA guideline, this is mainly because there is limited quality evidence on this topic and no randomized trials directly demonstrated better clinical outcomes with intensive BP control <130/80 mm Hg in diabetic patients. 2,9 Therefore, more quality studies are needed to solve this uncertainty and guide clinical practice. Furthermore, cost-benefit analysis of treating diabetic patients with stage 1 hypertension would give us additional information from public health perspective.…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, diabetic patients represented the entire population in two of the trials, and they were also included in two of the remaining trials. Our group is currently preparing separate systematic reviews and meta-analyses to evaluate whether targets lower than 130/80 mmHg, as recommended in clinical guidelines, reduce morbidity or mortality as compared with standard targets in patients with diabetes or chronic renal disease [20]. Preliminary results seem to show some clinical benefits with a diastolic target lower than 80 mmHg instead of lower than 90 mmHg in persons with diabetes, basically due to the subgroup analysis in HOT [14].…”
Section: New Evidence On Diastolic Blood Pressure Targetsmentioning
confidence: 99%